Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection

Summary

In light of the ongoing COVID-19 epidemic in Norway, it is paramount to develop and utilize clinical tools for assessing and risk stratifying patients with suspected coronary infection in the emergency departments. Diagnostic use of ultrasound in viral pneumonias, including COVID-19 has proved to be very useful. The use of ultrasound will assist in quick detection of lung pathology compatible with increasing severity of the COVID-19 disease. At the same time, the use of ultrasound diagnostics in the emergency department could improve logistics and reduce potential exposure of the corona virus to other health personnel.

The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.

Conditions

• COVID-19
• Pneumonia, Viral
• Pulmonary Infection

Interventions

DIAGNOSTIC_TEST

Lung ultrasound

After verbal consent the enrolled patients' lungs are evaluated with ultrasound while in isolation. The lungs are divided into 3 fields and findings are categorized according to Soldati et al., 2020.

Sponsors & Collaborators

• Haukeland University Hospital

  collaborator OTHER

• Ullevaal University Hospital

  collaborator OTHER

• Nordlandssykehuset HF

  collaborator OTHER

• Sorlandet Hospital HF

  collaborator OTHER_GOV

• Drammen sykehus

  collaborator OTHER

• Sykehuset Telemark

  collaborator OTHER_GOV

• Helse Stavanger HF

  collaborator OTHER_GOV

• University Hospital, Akershus

  collaborator OTHER

• St. Olavs Hospital

  lead OTHER

Principal Investigators

• Lars Petter Bjørnsen, MD, PhD · NTNU/St. Olav's Hospital

Eligibility

Min Age

17 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-07-01

Primary Completion

2021-06-15

Completion

2021-06-15

Countries

• Norway

Study Locations